Rheumatology News

• Alert FDA Approves First Tocilizumab Biosimilar Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
  FDA Approvals, September 29, 2023
• What Potential Does AI Offer for Endocrinology? With its vast complexities, endocrinology could notably benefit from AI -- once wrinkles are ironed out.
  Medscape Medical News, September 28, 2023
• Don't Ask Patients for Donations, ACP Says Clinicians should avoid involvement in grateful patient fundraising, according to a new report from the American College of Physicians.
  Medscape Medical News, September 26, 2023
• Ginger Consumption May Mitigate Neutrophil Dysfunction An oral ginger extract was associated with reduced action of the neutrophil activity associated with the development of autoimmune and inflammatory diseases.
  Medscape Medical News, September 22, 2023
• CV Disease, Drug Abuse Big Contributors to Mortality in AS Congestive heart failure and renal disease were the strongest contributing comorbidities to mortality in hospitalized patients with ankylosing spondylitis.
  Medscape Medical News, September 22, 2023
• Patients With Rheumatism Have Premature Immune System Aging Researchers have studied how the T-cell aging process translates into metabolic reprogramming of the T-cells in patients with rheumatoid arthritis.
  Medscape Medical News, September 22, 2023
• Worm Pulled From Woman's Brain in Case That 'Stunned' A 64-year-old woman diagnosed with pneumonia had abdominal pain, diarrhea, dry cough, and night sweats. A year of inexplicable symptoms ended in an open biopsy and a live, stringlike worm.
  Medscape Medical News, September 22, 2023
• Are Vitamin D Levels Key to Canagliflozin's Fracture Risk? Study findings suggest that patients be screened for vitamin D deficiency before starting SGLT2 inhibitor therapy, or they should simply be prescribed vitamin D supplements.
  Medscape Medical News, September 22, 2023
• European Commission Approves First Tocilizumab Biosimilar The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.
  Medscape Medical News, September 20, 2023
• Study Confirms Psoriasis Linked to Higher Heart Disease Risk To date, the study is the largest to explore the relationship between severe psoriasis and coronary microvascular dysfunction.
  Medscape Medical News, September 20, 2023
• ERS 2023 Progressive Pulmonary Fibrosis: Treatment and Support Numerous unresolved questions surround PPF treatment and support.
  Medscape Medical News, September 19, 2023
• Do Docs Have a Right to Work From Home Due to Health Issues? A radiologist with a health condition sued his hospital to be able to work remotely. Find out what happened and what to do if you're in this situation and your accommodation request is denied.
  Medscape Medical News, September 19, 2023
• The Top Tax Breaks That Physicians Use Physicians told us which tax deductions they most often use when preparing their annual tax return.
  Medscape Medical News, September 19, 2023
• Bristol Myers Plans to Double Experimental Treatments Bristol Myers Squibb has said it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies, over the next 18 months.
  Reuters Health Information, September 14, 2023
• Lupus May Overlap in Many Patients With Systemic Sclerosis Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) showed a distinct clinical phenotype from those with SSc alone, but mortality was similar.
  Medscape Medical News, September 15, 2023
• Extraarticular RA Manifestations: Mortality Still a Problem The incidence of nonsevere extraarticular manifestations of RA decreased over time, likely because of a reduced incidence of rheumatoid nodules.
  Medscape Medical News, September 14, 2023
• Benralizumab Hits Mark in Head-to-Head EGPA Vasculitis Trial In the study, adults with EGPA were randomized to a single 30-mg subcutaneous injection of benralizumab or three separate 100-mg subcutaneous injections of mepolizumab once every 4 weeks.
  MDedge News, September 13, 2023
• Steroid Bridging in RA Gets New Support, but Concerns Remain At issue is whether patients with early RA should be temporarily treated with glucocorticoids in order to provide rapid relief.
  MDedge News, September 13, 2023
• Universal Monovalent COVID Vaccines Backed by CDC With COVID hospitalizing about 17,000 people a week in the US, according to the CDC, the CDC's Advisory Committee on Immunization Practices voted nearly unanimously in favor of new XBB-containing shots.
  Medscape Medical News, September 12, 2023
• HCQ Blood Level 'Sweet Spot' May Maximize Efficacy in Lupus Researchers identified a blood-level reference range linked with 71% lower odds of active lupus.
  Medscape Medical News, September 12, 2023
• Rheumatology Trials Seem Vulnerable to Unblinding: Report Until more is known about the potential for unblinding, clinicians need to keep in mind that patients and physicians could often guess accurately who was getting placebo or active drug.
  MDedge News, August 29, 2023
• CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease CAR–T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.
  Medscape Medical News, August 24, 2023
• As MOC Debate Heats Up, Cardiology Societies Weigh In The MOC process is once again under attack by cardiologists and other specialty physicians. A petition aiming to end the requirements has garnered more than 17,000 and counting signatures.
  Medscape Medical News, August 22, 2023
• Innovations in Pediatric Chronic Pain Management The most important development in chronic pediatric pain has been the growth of rehab centers that include the medical team, practitioners from psychology, and occupational and physical therapy.
  MDedge News, August 01, 2023
• Rheumatoid Arthritis May Raise Risk for Aortic Stenosis Data from a large cohort study also showed an increase in risk for aortic stenosis–related interventions and death.
  Medscape Medical News, July 31, 2023